# FDA Inspection 898235 - GlaxoSmithKline LLC - September 29, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/glaxosmithkline-llc/eeb9cc30-e96a-4e77-89cb-4345bcc0d9fd/
Source feed: FDA_Inspections

> FDA Inspection 898235 for GlaxoSmithKline LLC on September 29, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 898235
- Company Name: GlaxoSmithKline LLC
- Inspection Date: 2014-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1230726 - 2024-08-16](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-llc/13c32f4d-414a-4526-845d-350d12295277/)
- [FDA Inspection 1103284 - 2019-09-12](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-llc/fbf6b937-d3c2-4538-b1fb-8a2081d0f4d8/)
- [FDA Inspection 988235 - 2016-07-15](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-llc/53d064fa-5f58-4b4c-93f0-cf5e2a0894d9/)
- [FDA Inspection 921712 - 2015-04-10](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-llc/599ec738-a209-474c-83fe-b9e3a029c589/)
- [FDA Inspection 817398 - 2013-02-05](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-llc/218356ac-c71c-4485-9ee1-d72dc2a20cc0/)

Company: https://www.globalkeysolutions.net/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c